Exchange Traded Concepts’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,814
Closed -$105K 1485
2025
Q1
$105K Sell
10,814
-5,196
-32% -$64.3K ﹤0.01% 1145
2024
Q4
$194K Hold
16,010
﹤0.01% 1001
2024
Q3
$175K Sell
16,010
-8,574
-35% -$87.1K ﹤0.01% 1003
2024
Q2
$221K Sell
24,584
-7,648
-24% -$53.3K 0.01% 862
2024
Q1
$263K Buy
32,232
+24,395
+311% +$200K 0.01% 848
2023
Q4
$66.1K Buy
7,837
+1,988
+34% +$23K ﹤0.01% 922
2023
Q3
$100K Sell
5,849
-49
-0.8% -$962 ﹤0.01% 895
2023
Q2
$137K Buy
+5,898
New +$115K ﹤0.01% 870

Other funds holding REPL

Exchange Traded Concepts's REPL Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Replimune Group (REPL) in Q2 2025, closing a stake of 10,814 shares — an estimated $105K sold.

Exchange Traded Concepts first reported a position in REPL in Q2 2023 and held it in 8 quarters. The position peaked at $263K in Q1 2024. 174 funds tracked by Wall St. Rank hold REPL as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Replimune Group position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 10,814 Replimune Group shares in Q2 2025, an estimated $105K.
  • Exchange Traded Concepts first reported a position in Replimune Group in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Replimune Group position peaked at $263K in Q1 2024.
  • 174 funds tracked by Wall St. Rank held Replimune Group as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.